⌕
Organon · OGN · NYSE
Tenet 45 · Mixed
Compare
$13.900.00%At closeTenet 45 · Mixed
$13.900.00 (0.00%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Organon (OGN) Stock

Organon (OGN) closed at $13.90 on Nov 17, 2026; its Tenet Score is 45 of 100 against 340 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

2 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$13.90
Nov 17, 2026
Market cap
$3.7B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
17.8×
TTM through Sep 30, 2026 · as of close, Nov 16, 2026
Dividend yield
0.58%
past year's regular dividends ÷ price · as of close, Nov 16, 2026
52-week range
5.69 – 13.91
low → high · as of close, Nov 16, 2026
Tenet Score
45/100
Mixed · 340 Healthcare peers

Industry: Drugs

Organon & Co. scores 45/100. Mixed. Strongest on value, financial health is the soft spot, trading at 18× earnings versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
45/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
82
Quality
57
Health
18
Growth
24

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueBQualityCHealthFGrowthFMomentumA
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
3.1×
Sep 30, 2026 balance sheet
P/S
0.6×
price to sales, TTM through Sep 30, 2026 · as of close, Nov 16, 2026
ROE
20%
TTM through Sep 30, 2026
Operating margin
13.3%
fiscal 2025, before interest and tax
Net margin
3.5%
TTM through Sep 30, 2026
Current ratio
2.02
Sep 30, 2026 balance sheet
Net debt / EBITDA
6.0×
TTM through Sep 30, 2026
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.

The whole report, at a glance · every card is a live peek, click any to open the section

About Organon & Co.

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 123 US ETFs · top wrappers by weightSee all ETFs holding OGN →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

What sector and industry is Organon in?

Organon is in the Healthcare sector and the Drugs industry.

What is Organon's Tenet Score?

Organon's Tenet Score is 45 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.